Selected research
Industry Research
Human Covid-19 Protein Industry Research Report 2026
Market perspective
The global Human Covid-19 Protein market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Human Covid-19 Protein is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Human Covid-19 Protein is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Human Covid-19 Protein is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Human Covid-19 Protein include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Human Covid-19 Protein market in revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Human Covid-19 Protein.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Human Covid-19 Protein Market by Company
Seebio
Merck KGaA (Sigma-Aldrich)
Thermo Fisher Scientific
The Native Antigen Company
Abcam
Agrisera
Bio-Rad Laboratories
Elabscience
Novus Biologicals
Human Covid-19 Protein Segment by Type
Purity＞95%
90%≤Purity≤95%
Other
Human Covid-19 Protein Segment by Application
Vaccine Development
Research
Antiviral Drugs
Other
Human Covid-19 Protein Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Covid-19 Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Covid-19 Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Covid-19 Protein.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Covid-19 Protein manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Covid-19 Protein by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Covid-19 Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity＞95%
- 90%≤Purity≤95%
- Other
Applications
- Vaccine Development
- Research
- Antiviral Drugs
- Other
Companies covered
- Seebio
- Merck KGaA (Sigma-Aldrich)
- Thermo Fisher Scientific
- The Native Antigen Company
- Abcam
- Agrisera
- Bio-Rad Laboratories
- Elabscience
- Novus Biologicals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Human Covid-19 Protein by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Purity＞95%
- 2.2.3 90%≤Purity≤95%
- 2.2.4 Other
- 2.3 Human Covid-19 Protein by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Vaccine Development
- 2.3.3 Research
- 2.3.4 Antiviral Drugs
- 2.3.5 Other
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Human Covid-19 Protein Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Human Covid-19 Protein Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Human Covid-19 Protein Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Human Covid-19 Protein Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Human Covid-19 Protein Production by Manufacturers (2021-2026)
- 3.2 Global Human Covid-19 Protein Production Value by Manufacturers (2021-2026)
- 3.3 Global Human Covid-19 Protein Average Price by Manufacturers (2021-2026)
- 3.4 Global Human Covid-19 Protein Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Human Covid-19 Protein Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Human Covid-19 Protein Manufacturers, Product Type & Application
- 3.7 Global Human Covid-19 Protein Manufacturers Established Date
- 3.8 Global Human Covid-19 Protein Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Seebio
- 4.1.1 Seebio Human Covid-19 Protein Company Information
- 4.1.2 Seebio Human Covid-19 Protein Business Overview
- 4.1.3 Seebio Human Covid-19 Protein Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Seebio Product Portfolio
- 4.1.5 Seebio Recent Developments
- 4.2 Merck KGaA (Sigma-Aldrich)
- 4.2.1 Merck KGaA (Sigma-Aldrich) Human Covid-19 Protein Company Information
- 4.2.2 Merck KGaA (Sigma-Aldrich) Human Covid-19 Protein Business Overview
- 4.2.3 Merck KGaA (Sigma-Aldrich) Human Covid-19 Protein Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Merck KGaA (Sigma-Aldrich) Product Portfolio
- 4.2.5 Merck KGaA (Sigma-Aldrich) Recent Developments
- 4.3 Thermo Fisher Scientific
- 4.3.1 Thermo Fisher Scientific Human Covid-19 Protein Company Information
- 4.3.2 Thermo Fisher Scientific Human Covid-19 Protein Business Overview
- 4.3.3 Thermo Fisher Scientific Human Covid-19 Protein Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Thermo Fisher Scientific Product Portfolio
- 4.3.5 Thermo Fisher Scientific Recent Developments
- 4.4 The Native Antigen Company
- 4.4.1 The Native Antigen Company Human Covid-19 Protein Company Information
- 4.4.2 The Native Antigen Company Human Covid-19 Protein Business Overview
- 4.4.3 The Native Antigen Company Human Covid-19 Protein Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 The Native Antigen Company Product Portfolio
- 4.4.5 The Native Antigen Company Recent Developments
- 4.5 Abcam
- 4.5.1 Abcam Human Covid-19 Protein Company Information
- 4.5.2 Abcam Human Covid-19 Protein Business Overview
- 4.5.3 Abcam Human Covid-19 Protein Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Abcam Product Portfolio
- 4.5.5 Abcam Recent Developments
- 4.6 Agrisera
- 4.6.1 Agrisera Human Covid-19 Protein Company Information
- 4.6.2 Agrisera Human Covid-19 Protein Business Overview
- 4.6.3 Agrisera Human Covid-19 Protein Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Agrisera Product Portfolio
- 4.6.5 Agrisera Recent Developments
- 4.7 Bio-Rad Laboratories
- 4.7.1 Bio-Rad Laboratories Human Covid-19 Protein Company Information
- 4.7.2 Bio-Rad Laboratories Human Covid-19 Protein Business Overview
- 4.7.3 Bio-Rad Laboratories Human Covid-19 Protein Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Bio-Rad Laboratories Product Portfolio
- 4.7.5 Bio-Rad Laboratories Recent Developments
- 4.8 Elabscience
- 4.8.1 Elabscience Human Covid-19 Protein Company Information
- 4.8.2 Elabscience Human Covid-19 Protein Business Overview
- 4.8.3 Elabscience Human Covid-19 Protein Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Elabscience Product Portfolio
- 4.8.5 Elabscience Recent Developments
- 4.9 Novus Biologicals
- 4.9.1 Novus Biologicals Human Covid-19 Protein Company Information
- 4.9.2 Novus Biologicals Human Covid-19 Protein Business Overview
- 4.9.3 Novus Biologicals Human Covid-19 Protein Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Novus Biologicals Product Portfolio
- 4.9.5 Novus Biologicals Recent Developments
5 Global Human Covid-19 Protein Production by Region
- 5.1 Global Human Covid-19 Protein Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Human Covid-19 Protein Production by Region: 2021-2032
- 5.2.1 Global Human Covid-19 Protein Production by Region: 2021-2026
- 5.2.2 Global Human Covid-19 Protein Production Forecast by Region (2027-2032)
- 5.3 Global Human Covid-19 Protein Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Human Covid-19 Protein Production Value by Region: 2021-2032
- 5.4.1 Global Human Covid-19 Protein Production Value by Region: 2021-2026
- 5.4.2 Global Human Covid-19 Protein Production Value Forecast by Region (2027-2032)
- 5.5 Global Human Covid-19 Protein Market Price Analysis by Region (2021-2026)
- 5.6 Global Human Covid-19 Protein Production and Value, YOY Growth
- 5.6.1 North America Human Covid-19 Protein Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Human Covid-19 Protein Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Human Covid-19 Protein Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Human Covid-19 Protein Production Value Estimates and Forecasts (2021-2032)
6 Global Human Covid-19 Protein Consumption by Region
- 6.1 Global Human Covid-19 Protein Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Human Covid-19 Protein Consumption by Region (2021-2032)
- 6.2.1 Global Human Covid-19 Protein Consumption by Region: 2021-2026
- 6.2.2 Global Human Covid-19 Protein Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Human Covid-19 Protein Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Human Covid-19 Protein Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Human Covid-19 Protein Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Human Covid-19 Protein Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Human Covid-19 Protein Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Human Covid-19 Protein Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Human Covid-19 Protein Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Human Covid-19 Protein Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Human Covid-19 Protein Production by Type (2021-2032)
- 7.1.1 Global Human Covid-19 Protein Production by Type (2021-2032) & (Kg)
- 7.1.2 Global Human Covid-19 Protein Production Market Share by Type (2021-2032)
- 7.2 Global Human Covid-19 Protein Production Value by Type (2021-2032)
- 7.2.1 Global Human Covid-19 Protein Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Human Covid-19 Protein Production Value Market Share by Type (2021-2032)
- 7.3 Global Human Covid-19 Protein Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Human Covid-19 Protein Production by Application (2021-2032)
- 8.1.1 Global Human Covid-19 Protein Production by Application (2021-2032) & (Kg)
- 8.1.2 Global Human Covid-19 Protein Production Market Share by Application (2021-2032)
- 8.2 Global Human Covid-19 Protein Production Value by Application (2021-2032)
- 8.2.1 Global Human Covid-19 Protein Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Human Covid-19 Protein Production Value Market Share by Application (2021-2032)
- 8.3 Global Human Covid-19 Protein Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Human Covid-19 Protein Value Chain Analysis
- 9.1.1 Human Covid-19 Protein Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Human Covid-19 Protein Production Mode & Process
- 9.2 Human Covid-19 Protein Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Human Covid-19 Protein Distributors
- 9.2.3 Human Covid-19 Protein Customers
10 Global Human Covid-19 Protein Analyzing Market Dynamics
- 10.1 Human Covid-19 Protein Industry Trends
- 10.2 Human Covid-19 Protein Industry Drivers
- 10.3 Human Covid-19 Protein Industry Opportunities and Challenges
- 10.4 Human Covid-19 Protein Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst